# Pancreatic Cancer Study Finds Racial Differences in Tumor Cells

> Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments.
- Title: Pancreatic Cancer Study Finds Racial Differences in Tumor…
- Summary: Researchers discover Black patients have fewer common pancreatic cancer cells but more immune cell clusters, hinting at personalized treatments.
- Keywords: pancreatic cancer, racial differences, tumor cells, immune cells, personalized treatments, university of cincinnati, nina steele, dr. raymond wadlow, inova schar cancer institute, New York Post
- URL: https://shortify.news/New_York_Post/pancreatic-cancer-study-finds-racial-differences-in-tumor-ce
- Source: New York Post — https://nypost.com/2026/11/17/health/pancreatic-cancer-mystery-deepens-as-researchers-make-unexpected-discovery
- Published: 2026-11-17T16:51:51+00:00
- Read time: 1 min
- Topics: pancreatic cancer, racial differences, tumor cells, immune cells, personalized treatments, university of cincinnati, nina steele, dr. raymond wadlow, inova schar cancer institute, news, entertainment
## Study Finds Racial Differences in Pancreatic Tumors
A University of Cincinnati study found differences in pancreatic tumors that could help explain why that type of cancer affects some patients differently, potentially leading to more personalized treatments.
## 22 Tumors from Diverse Patients Analyzed
Researchers examined 22 pancreatic tumors from patients of different racial backgrounds across the U.S., looking for differences in cancer cells and how the immune system responds to them.
## Black Patients Show Fewer Common Cancer Cells
Tumors from Black patients had fewer of the most common type of pancreatic cancer cells and more cells with a mix of different characteristics, the researchers found.
## More Immune Cells in Black Patients
Additionally, tumors from Black patients contained more B cells, a type of immune cell, and larger clusters of immune cells.
## Immunotherapy Challenges in Pancreatic Cancer
Dr. Raymond Wadlow, a gastrointestinal medical oncologist at Inova Schar Cancer Institute in Virginia, said that using immunotherapy to help the immune system attack the disease has been particularly challenging in pancreatic cancer.

> That’s been very difficult to do in pancreatic cancer because the pancreatic tumor subverts the immune system so that it is fighting for it instead of for the host or the rest of the body
## Study Highlights Racial Inclusion in Research
The findings highlight the importance of including patients from different backgrounds in cancer research, according to lead study author Nina Steele, Ph.D., an assistant professor in UC’s College of Medicine.

> This study shows that ignoring diverse ancestry in medical research leaves blind spots in the search for a cure
## Potential for Personalized Treatments
Wadlow noted that pancreatic cancers can share major DNA mutations but can differ considerably in how their cells behave and interact with nearby immune cells and surrounding tissue.
## Limitations and Future Steps
Researchers have not established how the intermediate tumor cells affect survival or whether they respond differently to standard chemotherapy, Steele said.
## Key takeaway

Pancreatic tumors from Black patients show fewer common cancer cells and more immune cell clusters, potentially improving treatment personalization.

---

Summary: Shortify — https://shortify.news/New_York_Post/pancreatic-cancer-study-finds-racial-differences-in-tumor-ce
Reporting: New York Post — https://nypost.com/2026/11/17/health/pancreatic-cancer-mystery-deepens-as-researchers-make-unexpected-discovery

When you use this summary, link the Shortify URL for the summary and credit the reporting to its newsroom.